Avsnittsbeskrivning
LIS Technologies (LIST) is a young company with deep historical roots. CRISLA (Condensation Repression Isotope Selective Laser Activation), its laser isotope separation concept was developed and tested during the late 1980s and early 1990s under the leadership of Dr. Jeff Eerkens. Unfortunately, the path towards commercializing the technology hit a multi-decade detour as the result of terrible timing and a slow analytical process.
At the same time that the CRISLA development effort began producing intriguing results, there was a major effort to consume excess enriched uranium from the…
Webbplats: atomicinsights.com

